Diagnostic News and Research

RSS

University of Oslo researchers find the cause of coeliac disease

Professor Ludvig M. Sollid and his colleagues at the University of Oslo have found the cause of coeliac disease. To do so required really going into depth, right down to molecular level.

1 Jul 2015

Benefit and harm of vision screening in preschool-aged children still unclear

It remains unclear whether a special ophthalmological examination of all children younger than 6 years (and potential follow-up treatments) would reduce the frequency and severity of visual impairment (amblyopia) in the population. An update search conducted for a benefit assessment of the German Institute for Quality and Efficiency in Health Care from 2008 identified no new screening study.

1 Jul 2015

Nuclea and Aelan partner to develop, commercialize novel biomarker tests using STEM cells as models

Nuclea Biotechnologies Inc. announced today that it is partnering with Aelan Cell Technologies Inc. (San Francisco, California) for the development, validation and commercialization of novel biomarker tests and companion diagnostics using human STEM cells as models.

1 Jul 2015

Roswell Park, Lakeshore Cancer Center partner to improve access to cancer care for Nigerians

America's oldest cancer center and one of the world's newest oncology centers are partnering to improve access to cancer prevention, screening and care for the people of Nigeria. Roswell Park Cancer Institute and Lakeshore Cancer Center have announced an affiliation that will see Roswell Park faculty providing clinical consultations to assist LCC oncologists, who will also have access to both training at RPCI and continuing professional education seminars they can participate in remotely.

1 Jul 2015

Study supports need for diagnostic analysis of germline and tumor biomarker information

A core tenet of precision medicine is that predictive biomarkers can enhance therapeutic decision-making. In a new pilot study, scientists at Molecular Health analyzed a randomly selected set of 250 patients with solid tumors and detected predictive biomarkers in more than 85% of tumors.

30 Jun 2015

U.S. medical imaging market estimated to reach $82 million by 2019

Medical imaging is a notoriously data intensive field with its volume, variety and speed of data generation multiplying every day. Conventional tools are incapable of efficiently managing such large and complex datasets; posing limits on scalability, sustainability and usability. As the U.S. medical imaging field evolves from being not only data-intensive but also data-driven, big data tools are expected to better handle medical imaging, patient records, and improve workflow efficiency, diagnostic accuracy, treatment decisions and health management.

29 Jun 2015

Scientists examine rates of secondary mutations in biomarker genes

Many tests for predictive biomarkers in tumors focus on selected known mutations or regions (e.g. hotspot panels). In a new study, scientists at Molecular Health examined the rates of secondary mutations in known biomarker genes and their potential impact on the diagnostic reliability of specific single-nucleotide variant (SNV) biomarker testing.

29 Jun 2015

New educational infographic highlights risks to radiologist health and diagnostic accuracy from RSI

RedRick Technologies, a provider of ergonomic radiology furniture, monitor mounting solutions and reading room design guidance, has released a new educational infographic that highlights the significant risks to radiologist health and diagnostic accuracy from repetitive stress injuries (RSI).

27 Jun 2015

ACEP: Supreme Court verdict may not stem the rising tide of visits to emergency departments

The decision today by the Supreme Court will prevent millions of people from losing their health insurance, but does not stem the rising tide of visits to the nation's emergency departments or solve other problems emerging in the post-Affordable Care Act health care system, according to a statement from Dr. Michael Gerardi, president of the American College of Emergency Physicians (ACEP).

27 Jun 2015

Helen DeVos Children's Hospital uses two imaging techniques to produce hybrid 3D model of a patient's heart

Congenital heart experts from Spectrum Health Helen DeVos Children's Hospital have successfully integrated two common imaging techniques to produce a three-dimensional anatomic model of a patient's heart.

27 Jun 2015

SeraCare Life Sciences inks CRADA with NCI to create positive controls for cancer assays

SeraCare Life Sciences, a leading partner to global in vitro diagnostics manufacturers, today announced that it has signed a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute, part of the National Institutes of Health, to create reference materials and positive controls for cancer assays.

26 Jun 2015

New report on global market for point of care diagnostics

The market for point of care diagnostics reached $17 billion, in 2014, according to Kalorama Information. The term refers to diagnostic tests performed outside the central laboratory or decentralized.

26 Jun 2015

Animal study highlights major safety concern regarding use of MRI contrast agents in patients

New results in animals highlight a major safety concern regarding a class of magnetic resonance imaging (MRI) contrast agents used in millions of patients each year, according to a paper published online by the journal Investigative Radiology.

26 Jun 2015

University of Pittsburgh surgeon receives Anthony Cerami Award in Translational Medicine

The Feinstein Institute for Medical Research and Molecular Medicine announced today that the fourth Anthony Cerami Award in Translational Medicine will be conferred to Thomas E. Starzl, MD, PhD, professor of surgery at the University of Pittsburgh School of Medicine. The award is in recognition of his research in organ transplantation and alloengraftment mechanisms.

26 Jun 2015

Aeterna Zentaris selects Ergomed to manage Phase 3 clinical study of Macrilen

Aeterna Zentaris Inc. announced today that it has executed a definitive agreement with Ergomed PLC, pursuant to which Ergomed will manage the new, confirmatory Phase 3 clinical study to demonstrate the efficacy of Macrilen (macimorelin), a novel orally-active ghrelin agonist for use in evaluating adult growth hormone deficiency ("AGHD").

25 Jun 2015

Immune Pharmaceuticals begins bertilimumab Phase II clinical trials in Bullous Pemphigoid, Ulcerative Colitis

Immune Pharmaceuticals Inc. announced today that it has initiated its Phase II Ulcerative Colitis clinical trial and is scheduled to initiate its Phase II Bullous Pemphigoid clinical trial on July 1, 2015. Study Initiation is the training of hospital staff to allow for patient screening and immediate patient enrollment into the clinical trial upon selection.

25 Jun 2015

Diagnostic News and Research

University of Oslo researchers find the cause of coeliac disease

Benefit and harm of vision screening in preschool-aged children still unclear

Nuclea and Aelan partner to develop, commercialize novel biomarker tests using STEM cells as models

Roswell Park, Lakeshore Cancer Center partner to improve access to cancer care for Nigerians

Study supports need for diagnostic analysis of germline and tumor biomarker information

U.S. medical imaging market estimated to reach $82 million by 2019

Scientists examine rates of secondary mutations in biomarker genes

New educational infographic highlights risks to radiologist health and diagnostic accuracy from RSI

ACEP: Supreme Court verdict may not stem the rising tide of visits to emergency departments

Helen DeVos Children's Hospital uses two imaging techniques to produce hybrid 3D model of a patient's heart

SeraCare Life Sciences inks CRADA with NCI to create positive controls for cancer assays

New report on global market for point of care diagnostics

Animal study highlights major safety concern regarding use of MRI contrast agents in patients

University of Pittsburgh surgeon receives Anthony Cerami Award in Translational Medicine

Aeterna Zentaris selects Ergomed to manage Phase 3 clinical study of Macrilen

Immune Pharmaceuticals begins bertilimumab Phase II clinical trials in Bullous Pemphigoid, Ulcerative Colitis

Ebola diagnosis now possible within minutes

Omega-3 Coalition forms scientific advisory council to educate consumers about benefits, safety of omega-3s

Detroit-area patients contribute to national study that redefines diagnosis, treatment of glioma

Researchers emphasize need to define normal and abnormal emotions

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News